Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 3
2020 8
2021 4
2022 5
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Mogamulizumab for Previously Treated Mycosis Fungoides and Sézary Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Grimm SE, Witlox W, Wolff R, Chalker A, Hiligsmann M, Wijnen B, Ahmadu C, Ryder S, Armstrong N, Duffy S, Syndikus I, Kleijnen J, Joore MA. Grimm SE, et al. Among authors: witlox w. Pharmacoeconomics. 2022 May;40(5):509-518. doi: 10.1007/s40273-021-01098-3. Epub 2021 Oct 19. Pharmacoeconomics. 2022. PMID: 34664200 Free PMC article. Review.
Lenalidomide with Rituximab for Previously Treated Follicular Lymphoma and Marginal Zone Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Witlox WJA, Grimm SE, Riemsma R, Armstrong N, Ryder S, Duffy S, Carrera VH, Posadzki P, Worthy G, Pouwels XGLV, Ramaekers BLT, Kleijnen J, Joore MA, van Asselt ADI. Witlox WJA, et al. Pharmacoeconomics. 2021 Feb;39(2):171-180. doi: 10.1007/s40273-020-00971-x. Epub 2020 Nov 4. Pharmacoeconomics. 2021. PMID: 33145711 Free PMC article. Review.
Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Grimm SE, Fayter D, Ramaekers BLT, Petersohn S, Riemsma R, Armstrong N, Pouwels X, Witlox W, Noake C, Worthy G, Kleijnen J, Joore MA. Grimm SE, et al. Among authors: witlox w. Pharmacoeconomics. 2019 Oct;37(10):1195-1207. doi: 10.1007/s40273-019-00792-7. Pharmacoeconomics. 2019. PMID: 30895564 Free PMC article. Review.
Durvalumab for the Treatment of Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Witlox WJA, van Asselt ADI, Wolff R, Armstrong N, Worthy G, Chalker A, Buksnys T, Stirk L, Kleijnen J, Joore MA, Grimm SE. Witlox WJA, et al. Pharmacoeconomics. 2020 Apr;38(4):317-324. doi: 10.1007/s40273-019-00870-w. Pharmacoeconomics. 2020. PMID: 31814080 Free PMC article. Review.
Cannabidiol for Adjuvant Treatment of Seizures Associated with Lennox-Gastaut Syndrome and Dravet Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Wijnen B, Armstrong N, Ramaekers B, Witlox W, Westwood M, Fayter D, Ryder S, Buksnys T, Worthy G, Misso K, Grimm S, Kleijnen J, Joore M. Wijnen B, et al. Among authors: witlox w. Pharmacoeconomics. 2020 Oct;38(10):1043-1053. doi: 10.1007/s40273-020-00932-4. Pharmacoeconomics. 2020. PMID: 32514751 Review.
Fluocinolone Acetonide Intravitreal Implant for Treating Recurrent Non-infectious Uveitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Pouwels XGLV, Petersohn S, Carrera VH, Denniston AK, Chalker A, Raatz H, Armstrong N, Shah D, Witlox W, Worthy G, Noake C, Riemsma R, Kleijnen J, Joore MA. Pouwels XGLV, et al. Among authors: witlox w. Pharmacoeconomics. 2020 May;38(5):431-441. doi: 10.1007/s40273-019-00851-z. Pharmacoeconomics. 2020. PMID: 31701471 Free PMC article. Review.
Cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancer.
Witlox WJA, Ramaekers BLT, Lacas B, Le Pechoux C, Sun A, Wang SY, Hu C, Redman M, van der Noort V, Li N, Guckenberger M, van Tinteren H, Hendriks LEL, Groen HJM, Joore MA, De Ruysscher DKM. Witlox WJA, et al. Radiother Oncol. 2022 May;170:95-101. doi: 10.1016/j.radonc.2022.02.036. Epub 2022 Mar 5. Radiother Oncol. 2022. PMID: 35259416 Free article. Clinical Trial.
21 results